Is T. Rowe Price Personal Strategy Balanced (TRPBX) a Strong Mutual Fund Pick Right Now?

28.05.25 13:00 Uhr

Werte in diesem Artikel
Aktien

317,80 EUR -8,60 EUR -2,63%

Indizes

21.341,0 PKT -23,0 PKT -0,11%

19.113,8 PKT -62,1 PKT -0,32%

Any investors hoping to find an Allocation Balanced fund could think about starting with T. Rowe Price Personal Strategy Balanced (TRPBX). TRPBX possesses a Zacks Mutual Fund Rank of 3 (Hold), which is based on various forecasting factors like size, cost, and past performance.ObjectiveThe world of Zacks' Allocation Balanced funds is an area filled with options, such as TRPBX. These funds like to invest in a variety of asset types, finding a balance between stocks, bonds, cash, and sometimes even precious metals and commodities; they are mostly categorized by their respective asset allocation. For investors, Allocation Balanced funds can provide an entry point into diversified mutual funds, and present core holding options for a portfolio of funds.History of Fund/ManagerT. Rowe Price is based in Baltimore, MD, and is the manager of TRPBX. T. Rowe Price Personal Strategy Balanced made its debut in June of 1994, and since then, TRPBX has accumulated about $1.02 billion in assets, per the most up-to-date date available. A team of investment professionals is the fund's current manager.PerformanceInvestors naturally seek funds with strong performance. This fund carries a 5-year annualized total return of 7.87%, and it sits in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 6.4%, which places it in the middle third during this time-frame.It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. TRPBX's standard deviation over the past three years is 10.5% compared to the category average of 12.71%. The standard deviation of the fund over the past 5 years is 10.48% compared to the category average of 12.3%. This makes the fund less volatile than its peers over the past half-decade.Risk FactorsInvestors should note that the fund has a 5-year beta of 0.61, so it is likely going to be less volatile than the market at large. Another factor to consider is alpha, as it reflects a portfolio's performance on a risk-adjusted basis relative to a benchmark-in this case, the S&P 500. Over the past 5 years, the fund has a negative alpha of -2.59. This means that managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.ExpensesCosts are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal, a lower cost product will outperform its otherwise identical counterpart, so taking a closer look at these metrics is key for investors. In terms of fees, TRPBX is a no load fund. It has an expense ratio of 0.54% compared to the category average of 0.82%. TRPBX is actually cheaper than its peers when you consider factors like cost.Investors need to be aware that with this product, the minimum initial investment is $2,500; each subsequent investment needs to be at least $100.Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included.Bottom LineOverall, T. Rowe Price Personal Strategy Balanced ( TRPBX ) has a neutral Zacks Mutual Fund rank, and in conjunction with its comparatively similar performance, average downside risk, and lower fees, T. Rowe Price Personal Strategy Balanced ( TRPBX ) looks like a somewhat average choice for investors right now.Your research on the Allocation Balanced segment doesn't have to stop here. You can check out all the great mutual fund tools we have to offer by going to www.zacks.com/funds/mutual-funds to see the additional features we offer as well for additional information. Want to learn even more? We have a full suite of tools on stocks that you can use to find the best choices for your portfolio too, no matter what kind of investor you are.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Get Your Free (TRPBX): Fund Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Microstrategy und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Microstrategy

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Microstrategy

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Microstrategy

Wer­bung

Analysen zu Microstrategy

DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
28.07.2017Microstrategy A HoldDeutsche Bank AG
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
DatumRatingAnalyst
11.02.2019Microstrategy A BuyBWS Financial
27.10.2017Microstrategy A BuyMizuho
16.11.2016Microstrategy A BuyMizuho
11.01.2016Microstrateg a BuyDeutsche Bank AG
11.12.2015Microstrateg a BuyMizuho
DatumRatingAnalyst
28.07.2017Microstrategy A HoldDeutsche Bank AG
19.10.2015Microstrateg a HoldLake Street
31.10.2012Microstrateg a neutralROTH Capital Partners, LLC
30.10.2012Microstrateg a neutralUBS AG
31.07.2012Microstrateg a neutralUBS AG
DatumRatingAnalyst
16.03.2005Update Microstrategy Inc.: SellWedbush Morgan
09.02.2005Update Microstrategy Inc.: SellDeutsche Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Microstrategy nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen